Dharmacon Pockets $5.7M in Series A Financing Round

Aug 26, 2002

NEW YORK, Aug. 26 - Synthetic RNA developer Dharmacon Research has secured $5.7 million in a Series A round of private-equity financing.

Boulder Ventures led the round, which included investments by Telegraph Hill Partners.

The company, based in Lafayette, Colo., said it will use the cash to bolster R&D and automation.

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.